Recently, the applications of deep eutectic solvents (DESs) as green and sustainable solvents for the solubilization of functional foods and phytophenols have dramatically risen concerning global issues on the utilization of organic solvents. Nevertheless, developing a suitable DES system for phytocomponents to enhance its solubility and bioavailability is complex and requires a sound experimental setup. Herein, we have attempted to develop DES encompassing the choline chloride (ChCl) along with oxalic acid (OA), l-glutamine (l-Glu), urea (U), and glycerol (Gro) at different ratios to elicit the solubility and bioavailability of naringin (NAR).
View Article and Find Full Text PDFRecent Adv Drug Deliv Formul
July 2023
Deep eutectic solvents (DESs) containing bioactive have been explored as potential choices for therapeutic efficiency enhancement. DESs are regarded as superior compared to established solvents owing to accessibility, storage conditions, synthesis, and low cost. As such, intensive research has taken place in different disciplines, especially nutraceuticals, foods and pharmaceuticals.
View Article and Find Full Text PDFWe report herein the design of a solid self-microemulsifying drug delivery system (SMEDDS) of vitamin D for augmentation of its solubility and dissolution. The studies employed a 3 full factorial design by employing JMP 13.2.
View Article and Find Full Text PDFThe Alginate-Neusilin US2 micro-composite (MC) beads were fabricated and optimized for oral delivery of hesperidin (HES). A 3 full factorial design encompassing independent variables (factors) such as the concentration of sodium alginate (X), and Neusilin US2 (X) and dependant variables (response) such as particle size (Y), entrapment efficiency (Y), and swelling degree (Y). Nine batches were prepared by formulation design employing statistical software JMP 13.
View Article and Find Full Text PDFAim: The present study endeavours to develop a solid self-microemulsifying nutraceutical drug delivery system for hesperidin (HES) using quality by design (QbD) to improve its biopharmaceutical attributes.
Methods: A 3 full factorial design was employed to study the influence of factors on selected responses. Risk assessment was performed by portraying Ishikawa fishbone diagram and failure mode effect analysis (FMEA).